3,5-Dichloro-3'-fluoro-4'-methoxybenzophenone, 97.0%, 1g

tert-Butyl 2'-(methylthio)-6'-oxo-5'-(((trifluoromethyl)sulfonyl)oxy)-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylate, 97%, 50mg

(R)-2-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid, 97%, 1g

(S)-3-(6-bromo-1H-indol-3-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 250mg

L-Homoserine>98.0%(T)1g

1,3-Diethylurea, 95.0%, 1g

1-(5-methyl-2-thienyl)propan-1-one, 95.0%, 1g

3-(3-Bromophenyl)pyridine, 95.0%, 10g

2-Methoxy-5-aminobenzonitrile, 95.0%, 10g

(3-(Dimethylcarbamoyl)-4-fluorophenyl)boronic acid, 95.0%, 1g

3-Chloro-4-(trifluoromethyl)benzoyl fluoride, 95%, 1g

(S)-2-Amino-3-(3-(trifluoromethoxy)phenyl)propanoic acid, 95%, 1g

Tetramethylharnstoff, min. 99 %, zur Synthese, 100 ml, Glasverpackung